search button
Open Access

Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment

  • Authors:
    • Li Wang
    • Bing Liao
    • Jian Yu
    • Ling Chen
    • Xiaozhong Cai
    • Li Liu
    • Kaiwen Hou
    • Minghao Zhang

  • View Affiliations

  • Published online on: December 6, 2019     https://doi.org/10.3892/etm.2019.8206
  • Pages: 1121-1128

  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate the utility of the extent of change (C) and change rate (Cr) of cardiac troponin I (cTnI) and hypersensitive C‑reactive protein (hs‑CRP) prior to and after treatment in evaluating the early therapeutic efficacy of acute myocardial infarction (AMI) treatment. A total of 145 patients with AMI who received regular MI treatment were enrolled in the present study. Patients were divided into the effective group and the ineffective group based on the early therapeutic efficacy. The values of two parameters, namely the serum levels of cTnI and hs‑CRP, were collected prior to and after AMI treatment. Data were analyzed by using the t‑test, Chi‑squared test, logistic regression and receiver operating characteristic (ROC) curve analysis. Compared with those in the ineffective group, the values of cTnI and hs‑CRP after treatment [cTnI(post) and hs‑CRP(post)], as well as their C and Cr values, were significantly decreased in the effective group (P<0.01). Furthermore, the positive rates (PR) of cTnI(post), hs‑CRP(post), (cTnI+hs‑CRP)(post), C(cTnI), C(hs‑CRP) and C(cTnI+hs‑CRP) were significantly lower in the effective group compared with those in the ineffective group (P<0.01). It was indicated that hs‑CRP(post) and C(hs‑CRP), as well as the PR‑cTnI(post) and the PR‑C(cTnI), may be used as independent factors for early therapeutic efficacy evaluation (P<0.05). In addition, the area under the ROC curve, as well as the associated sensitivity and specificity analysis for cTnI(post), hs‑CRP(post), C(cTnI or hs‑CRP) and Cr(cTnI or hs‑CRP), all indicated that these parameters were able to distinguish between the effective and the ineffective groups. The present study revealed that compared with the cTnI(post) and hs‑CRP(post), the C and the Cr of cTnI and hs‑CRP may have enhanced value for evaluating the early therapeutic efficacy of AMI treatment.
View Figures
View References

Related Articles

Journal Cover

February-2020
Volume 19 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wang L, Liao B, Yu J, Chen L, Cai X, Liu L, Hou K and Zhang M: Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Exp Ther Med 19: 1121-1128, 2020.
APA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L. ... Zhang, M. (2020). Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment. Experimental and Therapeutic Medicine, 19, 1121-1128. https://doi.org/10.3892/etm.2019.8206
MLA
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19.2 (2020): 1121-1128.
Chicago
Wang, L., Liao, B., Yu, J., Chen, L., Cai, X., Liu, L., Hou, K., Zhang, M."Changes of cardiac troponin I and hypersensitive C‑reactive protein prior to and after treatment for evaluating the early therapeutic efficacy of acute myocardial infarction treatment". Experimental and Therapeutic Medicine 19, no. 2 (2020): 1121-1128. https://doi.org/10.3892/etm.2019.8206